NO823672L - Immunkompleks-fjerning og utvikling av tumorspesifikt antilegeme ved immobilisert protein a perfusjon og postperfusjon-legemiddelinfusjon - Google Patents

Immunkompleks-fjerning og utvikling av tumorspesifikt antilegeme ved immobilisert protein a perfusjon og postperfusjon-legemiddelinfusjon

Info

Publication number
NO823672L
NO823672L NO823672A NO823672A NO823672L NO 823672 L NO823672 L NO 823672L NO 823672 A NO823672 A NO 823672A NO 823672 A NO823672 A NO 823672A NO 823672 L NO823672 L NO 823672L
Authority
NO
Norway
Prior art keywords
plasma
immobilized
perfusion
protein
spa
Prior art date
Application number
NO823672A
Other languages
English (en)
Norwegian (no)
Inventor
David Stephen Terman
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of NO823672L publication Critical patent/NO823672L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO823672A 1981-11-06 1982-11-04 Immunkompleks-fjerning og utvikling av tumorspesifikt antilegeme ved immobilisert protein a perfusjon og postperfusjon-legemiddelinfusjon NO823672L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32332681A 1981-11-06 1981-11-06

Publications (1)

Publication Number Publication Date
NO823672L true NO823672L (no) 1983-05-09

Family

ID=23258717

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823672A NO823672L (no) 1981-11-06 1982-11-04 Immunkompleks-fjerning og utvikling av tumorspesifikt antilegeme ved immobilisert protein a perfusjon og postperfusjon-legemiddelinfusjon

Country Status (10)

Country Link
EP (1) EP0079221A3 (de)
JP (1) JPS5886168A (de)
KR (1) KR840002244A (de)
AU (1) AU570911B2 (de)
CA (1) CA1197460A (de)
DK (1) DK487382A (de)
ES (3) ES517174A0 (de)
FI (1) FI823761A7 (de)
IL (1) IL66959A0 (de)
NO (1) NO823672L (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120821A (ja) * 1983-12-05 1985-06-28 Asahi Chem Ind Co Ltd 悪性腫瘍治療用白血球刺激材および刺激方法
DE3422435A1 (de) * 1984-06-16 1986-01-16 B. Braun Melsungen Ag, 3508 Melsungen Verfahren und vorrichtung zur selektiven abtrennung pathologischer und/oder toxischer spezies aus blut oder blutplasma unter verwendung von filterkerzen
US4704366A (en) * 1984-06-22 1987-11-03 Bio-Rad Laboratories, Inc. Process for binding IgG to protein A
US4614513A (en) * 1984-08-13 1986-09-30 Fred Hutchinson Cancer Research Center Method and apparatus for treatment to remove immunoreactive substances from blood
US5122112A (en) * 1986-11-21 1992-06-16 Imre Corporation Antigen-specific removal of circulating immune complexes
SE8801426D0 (sv) * 1988-04-15 1988-04-15 Ulf Rothman Forfarande och medel for blodbehandling

Also Published As

Publication number Publication date
ES8501984A1 (es) 1984-12-16
FI823761A0 (fi) 1982-11-03
ES523790A0 (es) 1984-12-16
FI823761L (fi) 1983-05-07
EP0079221A3 (de) 1986-01-22
EP0079221A2 (de) 1983-05-18
DK487382A (da) 1983-05-07
KR840002244A (ko) 1984-06-25
ES8503202A1 (es) 1984-12-16
ES523791A0 (es) 1984-12-16
JPS5886168A (ja) 1983-05-23
IL66959A0 (en) 1983-02-23
FI823761A7 (fi) 1983-05-07
AU570911B2 (en) 1988-03-31
AU8918982A (en) 1985-02-07
CA1197460A (en) 1985-12-03
ES8402506A1 (es) 1983-12-01
ES517174A0 (es) 1983-12-01

Similar Documents

Publication Publication Date Title
US5091091A (en) Protein A perfusion and post perfusion drug infusion
Pollak et al. Renal vein thrombosis and the nephrotic syndrome
Greaves et al. Immunosuppressive potency and in-vitro activity of antilymphocyte globulin
Becker et al. Contractile proteins of endothelial cells, platelets and smooth muscle
Fagrell et al. Microcirculation: its significance in clinical and molecular medicine
GOLDE et al. Mixed cryoglobulins and glomerulonephritis
Cooper et al. Hypothermic circulatory arrest causes multisystem vascular endothelial dysfunction and apoptosis
Graber et al. Fatal heat stroke: Circulating endotoxin and gram-negative sepsis as complications
JPH09501066A (ja) 全血またはその成分からの選択された因子の除去
Terman et al. Specific removal of antibody by extracorporeal circulation over antigen immobilized in collodion-charcoal
Kellum et al. Blood purification in non-renal critical illness
Kishi et al. Pentoxifylline attenuates reperfusion injury in skeletal muscle after partial ischemia
Horton et al. Arginine in burn injury improves cardiac performance and prevents bacterial translocation
NO823672L (no) Immunkompleks-fjerning og utvikling av tumorspesifikt antilegeme ved immobilisert protein a perfusjon og postperfusjon-legemiddelinfusjon
Parving et al. Increased transcapillary escape rate of albumin, IgG, and IgM during angiotensin-II-induced hypertension in man
Miller et al. Bilateral renal vein thrombosis and the nephrotic syndrome: Associated with lesions of polyarteritis nodosa
Dieter et al. Studies on an undetermined circulating anticoagulant. Case report and laboratory findings
Fischer et al. Arterial stiffness and renal replacement therapy: a controversial topic
Wu et al. Abdominal aortic endothelial dysfunction occurs in female mice with dextran sodium sulfate-induced chronic colitis independently of reactive oxygen species formation
Stead et al. The Effect of the Injection of Histamine into the Brachial Artery on the Permeability of the Capillaries of the Forearm and Hand
Hsu et al. Lower prevalence of depression in hemodialysis patients who use polysulfone dialyzers
Tooke et al. The microcirculation and clinical disease
Wu et al. Zhang L, Xia X
Michels et al. The effects of chronic mesangial immune injury on glomerular function
NZ202367A (en) Therapeutic immunoadsorbent based on non-covalently immobilised protein a; blood plasma perfusion method and perfusion system